Reino Unido - inglês - MHRA (Medicines & Healthcare Products Regulatory Agency)

novartis pharmaceuticals uk ltd - midostaurin - capsule - 25mg

Malásia - inglês - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

novartis corporation (malaysia) sdn. bhd. - midostaurin -

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

tauropharm australia pty ltd - 57875 - non-antibiotic-based antimicrobial catheter lock solution - the device contains anticoagulants and antimicrobial substances. it is to be used with a port or a catheter-based vascular access device. it is to be instilled in the device lumens between treatments in order to make the internal flow passages resistant to clot formation and hostile to bacterial and fungal growth. the solution must be withdrawn prior to initiating the next treatment. taurolock-hep100 is indicated for those patients who use a port or a silicone or polyurethane catheter-based device as vascular access and is intended to be used as a catheter lock solution. it is to be instilled into the device at the termination of a treatment and withdrawn prior to initiating subsequent treatments.

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

tauropharm australia pty ltd - 57875 - non-antibiotic-based antimicrobial catheter lock solution - the device contains anticoagulants and antimicrobial substances. it is to be used with a port or a catheter-based vascular access device. it is to be instilled in the device lumens between treatments in order to make the internal flow passages resistant to clot formation and hostile to bacterial and fungal growth. the solution must be withdrawn prior to initiating the next treatment. taurolock-hep500 is indicated for those patients who use a port or a silicone or polyurethane catheter-based device as vascular access and is intended to be used as a catheter lock solution. it is to be instilled into the device at the termination of a treatment and withdrawn prior to initiating subsequent treatments.

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - midostaurin 25mg - soft gelatin capsule - 25 mg - active: midostaurin 25mg excipient: corn oil, ethoxylated dl-alpha tocopherol ethanol gelatin glycerol iron oxide red iron oxide yellow macrogol 400 peg-40 castor oil purified water red printing ink (catalent) titanium dioxide - rydapt® is indicated: · in combination with standard anthracycline and cytarabine induction and cytarabine consolidation chemotherapy, followed in patients in complete response by single agent maintenance therapy for adult patients with newly diagnosed acute myeloid leukemia (aml) who are flt3 mutation-positive · for the treatment of adult patients with aggressive systemic mastocytosis (asm), systemic mastocytosis with associated haematological neoplasms (sm-ahn), or mast cell leukaemia (mcl).

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

nutriforce pty ltd - taurine -

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

catalent australia pty ltd - ascorbic acid,biotin,calcium carbonate,calcium pantothenate,colecalciferol,cupric sulfate,cyanocobalamin,d-alpha-tocopherol,ferrous fumarate,folic acid,heavy magnesium oxide,manganese sulfate monohydrate,nicotinamide,potassium iodide,pyridoxine hydrochloride,retinol palmitate,riboflavine,taurine,thiamine nitrate,zinc sulfate monohydrate -

Austrália - inglês - APVMA (Australian Pesticides and Veterinary Medicines Authority)

wellpet, llc - omega 3 fatty acid; omega 6 fatty acid; s-lactic acid; amylase; cellulase; protease; total bacillus organisms; moisture; taurine; crude fat; crude fibre; crude protein; calcium; magnesium; phosphorus; ash; vitamin a; vitamin c = ascorbic acid; vitamin d; vitamin e - oral food (can/semi-dry/dry) - omega 3 fatty acid acid-fatty active 0.48 %; omega 6 fatty acid acid-fatty active 3.8 %; s-lactic acid ungrouped active 240.0 cfu/lb; amylase enzyme active 5.0 units/lb; cellulase enzyme active 100.0 units/lb; protease enzyme active 280.0 hut/lb; total bacillus organisms biological-organism active 7.0 cfu/lb; moisture ungrouped other 10.0 %; taurine amino zwitterion other 0.17 %; crude fat dietary other 20.0 %; crude fibre dietary other 3.8 %; crude protein dietary other 32.0 %; calcium mineral-calcium other 0.8 %; magnesium mineral-magnesium other 0.11 %; phosphorus mineral-phosphorus other 0.7 %; ash plant other 6.0 %; vitamin a vitamin-a other 22000.0 iu/kg; vitamin c = ascorbic acid vitamin-c other 30.0 mg/kg; vitamin d vitamin-d other 1200.0 iu/kg; vitamin e vitamin-e other 50.0 iu/kg - nutrition & metabolism - cat | cat - queen | cat - tom | kitten - prescription diet | dietary management of obesity, | early cardiac disease | food allergy | gastrointestinal disorders | hepatitus, kidney disease, | lower urinary tract support | pancreatitis, gastroenteritis | renal function | struvite urolithiasis

Austrália - inglês - APVMA (Australian Pesticides and Veterinary Medicines Authority)

wellpet, llc - omega 3 fatty acid; omega 6 fatty acid; s-lactic acid; amylase; cellulase; protease; total bacillus organisms; moisture; taurine; crude fat; crude fibre; crude protein; calcium; magnesium; phosphorus; ash; vitamin a; vitamin c = ascorbic acid; vitamin d; vitamin e - oral food (can/semi-dry/dry) - omega 3 fatty acid acid-fatty active 0.54 %; omega 6 fatty acid acid-fatty active 2.6 %; s-lactic acid ungrouped active 240.0 cfu/lb; amylase enzyme active 5.0 units/lb; cellulase enzyme active 100.0 units/lb; protease enzyme active 280.0 hut/lb; total bacillus organisms biological-organism active 7.0 cfu/lb; moisture ungrouped other 10.0 %; taurine amino zwitterion other 0.17 %; crude fat dietary other 14.0 %; crude fibre dietary other 7.0 %; crude protein dietary other 30.0 %; calcium mineral-calcium other 0.71 %; magnesium mineral-magnesium other 0.11 %; phosphorus mineral-phosphorus other 0.7 %; ash plant other 5.5 %; vitamin a vitamin-a other 22000.0 iu/kg; vitamin c = ascorbic acid vitamin-c other 30.0 mg/kg; vitamin d vitamin-d other 1200.0 iu/kg; vitamin e vitamin-e other 75.0 iu/kg - nutrition & metabolism - cat | kitten | cat - queen | cat - tom | kitten | young cat - prescription diet | dietary management of obesity, | early cardiac disease | food allergy | gastrointestinal disorders | hepatitus, kidney disease, | lower urinary tract support | pancreatitis, gastroenteritis | renal function | struvite urolithiasis

Austrália - inglês - APVMA (Australian Pesticides and Veterinary Medicines Authority)

jurox pty limited - taurine | iron as ferrous fumarate | iodine as potassium iodide | vitamin a acetate = retinyl acetate | choline | vitamin b3 = nicotinamide | vitamin b5 calcium salt = calcium pantothenate | vitamin b2 = riboflavin | vitamin b1 nitrate = thiamine nitrate | vitamin b6 hydrochloride = pyridoxine hydrochloride | vitamin d3 = cholecalciferol | vitamin e-dl acetate = alpha tocopherol acetate - nutrition & metabolism - cat | cat - queen | cat - tom | kitten - mineral and nutritional additive | acetonaemia | actinobacillosis | amino acid supplement | amino acids | bone fragility | bone growth | calcium supplement | cartilage strength | copper deficiency | egg shell | fatty acid deficiency | fatty liver | glucose | grass tetany | hepatotoxic drugs | hypocalcaemia | hypomagnesaemia | ileitis | iodine deficiencies | lactating | laxative | l-carnitine supplement | liver abscess | liver damage | lysine deficiencies | milk fever | mineral additive | myopathies | myositis syndrome | pangamic acid | phosphorous supplement | rickets | selenium deficiency | shell strength | soft bone disease | vitamin b12 | vitamin d supplement | vitamin e deficiencies | zinc deficiencies